-
Je něco špatně v tomto záznamu ?
Design, Synthesis, and Anticancer and Antibacterial Activities of Quinoline-5-Sulfonamides
A. Zieba, D. Pindjakova, M. Latocha, J. Plonka-Czerw, D. Kusmierz, A. Cizek, J. Jampilek
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
BNW-1-013/N/3/F
Medical University of Silesia in Katowice, Poland
PCN-1-048-2/F
Medical University of Silesia in Katowice, Poland
2018/31/B/NZ7/02122
Polish National Science Center
NLK
Directory of Open Access Journals
od 1997
Free Medical Journals
od 1997
PubMed Central
od 2001
Europe PubMed Central
od 2001
ProQuest Central
od 1997-01-01
Open Access Digital Library
od 1997-01-01
Medline Complete (EBSCOhost)
od 2009-03-01
Health & Medicine (ProQuest)
od 1997-01-01
- MeSH
- antibakteriální látky * farmakologie chemie chemická syntéza MeSH
- chinoliny * chemie farmakologie chemická syntéza MeSH
- Enterococcus faecalis účinky léků MeSH
- lidé MeSH
- mikrobiální testy citlivosti * MeSH
- molekulární struktura MeSH
- nádorové buněčné linie MeSH
- protinádorové látky * farmakologie chemie chemická syntéza MeSH
- racionální návrh léčiv MeSH
- Staphylococcus aureus účinky léků MeSH
- sulfonamidy * farmakologie chemie chemická syntéza MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
A series of new unique acetylene derivatives of 8-hydroxy- and 8-methoxyquinoline- 5-sulfonamide 3a-f and 6a-f were prepared by reactions of 8-hydroxy- and 8-methoxyquinoline- 5-sulfonyl chlorides with acetylene derivatives of amine. A series of new hybrid systems containing quinoline and 1,2,3-triazole systems 7a-h were obtained by reactions of acetylene derivatives of quinoline-5-sulfonamide 6a-d with organic azides. The structures of the obtained compounds were confirmed by 1H and 13C NMR spectroscopy and HR-MS spectrometry. The obtained quinoline derivatives 3a-f and 6a-f and 1,2,3-triazole derivatives 7a-h were tested for their anticancer and antimicrobial activity. Human amelanotic melanoma cells (C-32), human breast adenocarcinoma cells (MDA-MB-231), and human lung adenocarcinoma cells (A549) were selected as tested cancer lines, while cytotoxicity was investigated on normal human dermal fibroblasts (HFF-1). All the compounds were also tested against reference strains Staphylococcus aureus ATCC 29213 and Enterococcus faecalis ATCC 29212 and representatives of multidrug-resistant clinical isolates of methicillin-resistant S. aureus (MRSA) and vancomycin-resistant E. faecalis. Only the acetylene derivatives of 8-hydroxyquinoline-5-sulfonamide 3a-f were shown to be biologically active, and 8-hydroxy-N-methyl-N-(prop-2-yn-1-yl)quinoline-5-sulfonamide (3c) showed the highest activity against all three cancer lines and MRSA isolates. Its efficacies were comparable to those of cisplatin/doxorubicin and oxacillin/ciprofloxacin. In the non-cancer HFF-1 line, the compound showed no toxicity up to an IC50 of 100 μM. In additional tests, compound 3c decreased the expression of H3, increased the transcriptional activity of cell cycle regulators (P53 and P21 proteins), and altered the expression of BCL-2 and BAX genes in all cancer lines. The unsubstituted phenolic group at position 8 of the quinoline is the key structural fragment necessary for biological activity.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24019270
- 003
- CZ-PrNML
- 005
- 20241024111415.0
- 007
- ta
- 008
- 241015s2024 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/molecules29174044 $2 doi
- 035 __
- $a (PubMed)39274892
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Zieba, Andrzej $u Department of Organic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Jagiellonska 4, 41-200 Sosnowiec, Poland $1 https://orcid.org/0000000278413097
- 245 10
- $a Design, Synthesis, and Anticancer and Antibacterial Activities of Quinoline-5-Sulfonamides / $c A. Zieba, D. Pindjakova, M. Latocha, J. Plonka-Czerw, D. Kusmierz, A. Cizek, J. Jampilek
- 520 9_
- $a A series of new unique acetylene derivatives of 8-hydroxy- and 8-methoxyquinoline- 5-sulfonamide 3a-f and 6a-f were prepared by reactions of 8-hydroxy- and 8-methoxyquinoline- 5-sulfonyl chlorides with acetylene derivatives of amine. A series of new hybrid systems containing quinoline and 1,2,3-triazole systems 7a-h were obtained by reactions of acetylene derivatives of quinoline-5-sulfonamide 6a-d with organic azides. The structures of the obtained compounds were confirmed by 1H and 13C NMR spectroscopy and HR-MS spectrometry. The obtained quinoline derivatives 3a-f and 6a-f and 1,2,3-triazole derivatives 7a-h were tested for their anticancer and antimicrobial activity. Human amelanotic melanoma cells (C-32), human breast adenocarcinoma cells (MDA-MB-231), and human lung adenocarcinoma cells (A549) were selected as tested cancer lines, while cytotoxicity was investigated on normal human dermal fibroblasts (HFF-1). All the compounds were also tested against reference strains Staphylococcus aureus ATCC 29213 and Enterococcus faecalis ATCC 29212 and representatives of multidrug-resistant clinical isolates of methicillin-resistant S. aureus (MRSA) and vancomycin-resistant E. faecalis. Only the acetylene derivatives of 8-hydroxyquinoline-5-sulfonamide 3a-f were shown to be biologically active, and 8-hydroxy-N-methyl-N-(prop-2-yn-1-yl)quinoline-5-sulfonamide (3c) showed the highest activity against all three cancer lines and MRSA isolates. Its efficacies were comparable to those of cisplatin/doxorubicin and oxacillin/ciprofloxacin. In the non-cancer HFF-1 line, the compound showed no toxicity up to an IC50 of 100 μM. In additional tests, compound 3c decreased the expression of H3, increased the transcriptional activity of cell cycle regulators (P53 and P21 proteins), and altered the expression of BCL-2 and BAX genes in all cancer lines. The unsubstituted phenolic group at position 8 of the quinoline is the key structural fragment necessary for biological activity.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a protinádorové látky $x farmakologie $x chemie $x chemická syntéza $7 D000970
- 650 12
- $a antibakteriální látky $x farmakologie $x chemie $x chemická syntéza $7 D000900
- 650 12
- $a sulfonamidy $x farmakologie $x chemie $x chemická syntéza $7 D013449
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 12
- $a chinoliny $x chemie $x farmakologie $x chemická syntéza $7 D011804
- 650 12
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a racionální návrh léčiv $7 D015195
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 650 _2
- $a Staphylococcus aureus $x účinky léků $7 D013211
- 650 _2
- $a Enterococcus faecalis $x účinky léků $7 D013293
- 650 _2
- $a molekulární struktura $7 D015394
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Pindjakova, Dominika $u Department of Infectious Diseases and Microbiology, Faculty of Veterinary Medicine, University of Veterinary Sciences Brno, Palackeho 1946/1, 612 42 Brno, Czech Republic
- 700 1_
- $a Latocha, Malgorzata $u Department of Cell Biology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Jednosci 9, 41-200 Sosnowiec, Poland $1 https://orcid.org/0000000341092629
- 700 1_
- $a Plonka-Czerw, Justyna $u Department of Cell Biology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Jednosci 9, 41-200 Sosnowiec, Poland $1 https://orcid.org/000000030201525X
- 700 1_
- $a Kusmierz, Dariusz $u Department of Cell Biology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Jednosci 9, 41-200 Sosnowiec, Poland
- 700 1_
- $a Cizek, Alois $u Department of Infectious Diseases and Microbiology, Faculty of Veterinary Medicine, University of Veterinary Sciences Brno, Palackeho 1946/1, 612 42 Brno, Czech Republic $1 https://orcid.org/0000000157064601
- 700 1_
- $a Jampilek, Josef $u Institute of Chemistry, University of Silesia, Szkolna 9, 40-007 Katowice, Poland $1 https://orcid.org/0000000320039052 $7 xx0027075
- 773 0_
- $w MED00180394 $t Molecules (Basel, Switzerland) $x 1420-3049 $g Roč. 29, č. 17 (2024)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39274892 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20241015 $b ABA008
- 991 __
- $a 20241024111409 $b ABA008
- 999 __
- $a ok $b bmc $g 2201858 $s 1231243
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 29 $c 17 $e 20240826 $i 1420-3049 $m Molecules (Basel, Switzerland) $n Molecules $x MED00180394
- GRA __
- $a BNW-1-013/N/3/F $p Medical University of Silesia in Katowice, Poland
- GRA __
- $a PCN-1-048-2/F $p Medical University of Silesia in Katowice, Poland
- GRA __
- $a 2018/31/B/NZ7/02122 $p Polish National Science Center
- LZP __
- $a Pubmed-20241015